Despite decades of growth and adaptation in patient engagement, knowing or being able to find guidance for whichmodel or approach will be most impactful in which healthcare or research context … Read More
FoCUS Monthly Recap: September 2021
NEW RESOURCES Self-Insured Employers Workshop shares practical advice for covering cell and gene therapies In June FoCUS hosted a workshop for self-insured employers to help them understand the challenges and … Read More
LEAPS Monthly Recap: September 2021
NEW RESEARCH Precision for whom? Partnering with patients to ensure that Precision Medicine targets what matters Despite decades of growth and adaptation in patient engagement, knowing or being able to … Read More
Self-Insured Employers Workshop shares practical advice for covering cell and gene therapies
In June FoCUS hosted a workshop for self-insured employers to help them understand the challenges and potential solutions presented by new cell and gene therapies. In our event archive you … Read More
NEWDIGS + National Pharmaceutical Council in Health Affairs: Medicaid Best Price Volatility Could Inhibit Payment Innovation
Value-based payment (VBP) arrangements (also known as outcomes- or performance-based contracting) for drugs transform drug pricing from paying for expected benefits projected from clinical trials to paying for actual benefits … Read More
Upcoming book highlighting NEWDIGS Design Labs now available for pre-order
The LEAPS Project of the MIT NEWDIGS initiative is actively soliciting Use Cases for our workstream focused on methods innovation associated with “Integrating Evidence Using Meta-Analytic Approaches.” This methodology is … Read More
LEAPS seeking nominations for Predictive Outcomes Platform use case
The LEAPS Project of the MIT NEWDIGS initiative is actively soliciting Use Cases for our workstream focused on methods innovation associated with “Integrating Evidence Using Meta-Analytic Approaches.” This methodology is … Read More
Rebranding: Adaptive Reimbursement is now Precision Reimbursement
Adaptive Reimbursement evolved as a collaboration of our NEWDIGS LEAPS and FoCUS Projects. The goal of LEAPS is to advance the knowledge and practice of Precision Medicine by modernizing how … Read More
Tracking the CAR-T Revolution: Analysis of Clinical Trials of CAR-T and TCR-T Therapies for the Treatment of Cancer (1997–2020)
Ivica NA, Young CM. Healthcare. 2021; 9(8):1062. Chimeric antigen receptor and T-cell receptor (CAR-T/TCR-T) cellular immunotherapies have shown remarkable success in the treatment of some refractory B-cell malignancies, with potential … Read More
FoCUS Monthly Recap: June 2021
NEW WHITE PAPER Emerging market solutions for financing and reimbursement of durable cell and gene therapies The white paper reports the findings and analysis from a survey of organizations offering … Read More